BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer

2011411 citationsJournal Articlehybrid Open Access

Authors

Tomoya Yokota · Aichi Cancer Center

Takashi Ura · Aichi Cancer Center

Norio Shibata · Aichi Cancer Center

Daisuke Takahari · Aichi Cancer Center

Kohei Shitara · Aichi Cancer Center

Motoo Nomura · Aichi Cancer Center

Chiaki Kondo ·

Abstract

Presence of mutated BRAF is one of the most powerful prognostic factors for advanced and recurrent CRC. The KRAS13 mutation showed a trend towards poor OS in patients with advanced and recurrent CRC.

Topics & Keywords

Colorectal Cancer Treatments and Studies Genetic factors in colorectal cancer Hepatocellular Carcinoma Treatment and Prognosis

UN Sustainable Development Goals

No poverty

Publication Details

Published in: British Journal of Cancer

Volume 104, Issue 5, pp. 856-862

DOI: 10.1038/bjc.2011.19

Field-Weighted Citation Impact: 15.34